Cooperation of actin-sequestering protein, thymosin β-4 and hypoxia inducible factor-1α in tumor cell migration

Oncology Reports

Volumn 24, Issue 5, 2010, Pages 1389-1394

  Ryu, Yun Kyoung ^a   Im, Yun Sun ^a   Moon, Eun Yi ^a  

^a Sejong University   (South Korea)

Author keywords

HIF 1 ; Hypoxia conditioning; Thymosin 4; Tumor cell migration; VEGF

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; THYMOSIN BETA4; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CELL ACTIVITY; CELL MIGRATION; CONTROLLED STUDY; ENZYME INHIBITION; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR CELL;

ANIMALS; CELL HYPOXIA; CELL LINE; CELL MOVEMENT; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MELANOMA, EXPERIMENTAL; MICE; RNA, SMALL INTERFERING; THYMOSIN; TRANSFECTION;

EID: 78149311825     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000997     Document Type: Article

References (26)

1. Huff T, Muller CS, Otto AM, Netzker R and Hannappel E: Beta-thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol 33: 205-220, 2001.
2. Domanski M, Hertzog M, Coutant J, Gutsche-Perelroizen I, Bontems F, Carlier MF, Guittet E and van Heijenoort C: Coupling of folding and binding of thymosin beta4 upon interaction with monomeric actin monitored by nuclear magnetic resonance. J Biol Chem 279: 23637-23645, 2004.
3. Hertzog M, van Heijenoort C, Didry D, Gaudier M, Coutant J, Gigant B, Didelot G, Preat T, Knossow M, Guittet E and Carlier MF: The beta-thymosin/WH2 domain; structural basis for the switch from inhibition to promotion of actin assembly. Cell 117: 611-623, 2004.
4. Huff T, Otto AM, Muller CS, Meier M and Hannappel E: Thymosin beta4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen. FASEB J 16: 691-696, 2002.
5. Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL and Kleinman HK: Thymosin beta4 accelerates wound healing. J Invest Dermatol 113: 364-368, 1999.
6. Hsiao HL, Wang WS, Chen PM and Su Y: Overexpression of thymosin beta-4 renders SW480 colon carcinoma cells more resistant to apoptosis triggered by FasL and two topo-isomerase II inhibitors via downregulating Fas and upregulating Survivin expression, respectively. Carcinogenesis 27: 936-944, 2006.
7. Oh SY, Song JH, Gil JE, Kim JH, Yeom YI and Moon EY: ERK activation by thymosin-beta-4 (TB4) overexpression induces paclitaxel-resistance. Exp Cell Res 312: 1651-1657, 2006.
8. Cha HJ, Jeong MJ and Kleinman HK: Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst 95: 1674-1680, 2003.
9. Goldstein AL: Thymosin beta4: a new molecular target for antitumor strategies. J Natl Cancer Inst 95: 1646-1647, 2003.
10. Singer SJ and Kupfer A: T he directed migration of eukaryotic cells. Annu Rev Cell Biol 2: 337-365, 1986.
11. Webb DJ, Parsons JT and Horwitz AF: Adhesion assembly, disassembly and turnover in migrating cells, over and over and over again. Nat Cell Biol 4: E97-E100, 2002.
12. Lauffenburger DA and Horwitz AF: Cell migration: a physically integrated molecular process. Cell 84: 359-369, 1996.
13. Lee J, Ishihara A, Theriot JA and Jacobson K: Principles of locomotion for simple-shaped cells. Nature 362: 167-171, 1993.
14. Borisy GG and Svitkina TM: Actin machinery: pushing the envelope. Curr Opin Cell Biol 12: 104-112, 2000.
15. Pantaloni D, Le Clainche C and Carlier MF: Mechanism of actin-based motility. Science 292: 1502-1506, 2001.
16. Welch MD, Iwamatsu A and Mitchison TJ: Actin polymerization is induced by Arp2/3 protein complex at the surface of Listeria monocytogenes. Nature 385: 265-269, 1997.
17. Safer D and Nachmias VT: Beta thymosins as actin binding peptides. Bioessays 16: 473-479, 1994.
18. Oh JM, Ryoo IJ, Yang Y, Kim HS, Yang KH and Moon EY: Hypoxia-inducible transcription factor (HIF)-1 alpha stabilization by actin-sequestering protein, thymosin beta-4 (TB4) in Hela cervical tumor cells. Cancer Lett 264: 29-35, 2008.
19. Park SY, Jeong KJ, Lee J, Yoon DS, Choi WS, Kim YK, Han JW, Kim YM, Kim BK and Lee HY: Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. Cancer Lett 258: 63-69, 2007.
20. Follenzi A, Ailles LE, Bakovic S, Geuna M and Naldini L: Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 25: 217-222, 2000.
21. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D and Naldini L: A third-generation lentivirus vector with a conditional packaging system. J Virol 72: 8463-8471, 1998.
22. Jiang BH, Liu LZ, Schafer R, Flynn DC and Barnett JB: A novel role for 3, 4-dichloropropionanilide (DCPA) in the inhibition of prostate cancer cell migration, proliferation, and hypoxia-inducible factor 1alpha expression. BMC Cancer 6: 204, 2006.
23. Lin S, Sun L, Hu J, Wan S, Zhao R, Yuan S and Zhang L: Chemokine C-X-C motif receptor 6 contributes to cell migration during hypoxia. Cancer Lett 279: 108-117, 2009.
24. Aubert S, Fauquette V, Hemon B, Lepoivre R, Briez N, Bernard D, Van Seuningen I, Leroy X and Perrais M: MUC1, a new hypoxia inducible factor target gene, is an actor in clear renal cell carcinoma tumor progression. Cancer Res 69: 5707-5715, 2009.
25. Liu YL, Yu JM, Song XR, Wang XW, Xing LG and Gao BB: Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non-small cell lung cancer cell lines. Cancer Biol Ther 5: 1320-1326, 2006.
26. Minet E, Arnould T, Michel G, Roland I, Mottet D, Raes M, Remacle J and Michiels C: ERK activation upon hypoxia: involvement in HIF-1 activation. FEBS Lett 468: 53-58, 2000.